Response to British Journal of Sports & Exercise Medicine

The British Medical Journal Open Sports & Exercise Medicine recently published an article titled, “Normal platelet function in platelet concentrates requires non-platelet cells: a comparative in vitro evaluation of leukocyte-rich (type 1a) and leukocyte-poor (type 3b) platelet concentrates”.

 

Based on the outcomes of a study designed to evaluate the cellular components of platelet rich plasma (PRP), the authors claimed that leukocyte-rich PRP was superior to leukocyte-poor PRP when supporting the promotion of growth factor release and stimulation of tendon cell proliferation.

 

Leukocytes are white blood cells, a non-platelet component of platelet-rich plasma. There is current debate across the scientific and medical communities as to the role they play in platelet rich plasma treatments.

 

Dr. Marko Bodor, Ryan Dregalla, PhD and Yvette Uribe, BS read the article carefully and with great interest, given the current work they are doing in both clinical studies involving the delivery of PRP treatments and in laboratory research investigating PRP on a cellular level. They found inconsistencies in the authors’ preparation and use of the PRP within the study. The authors of the article did not actually use live PRP, but had frozen the platelets and used their extracts to stimulate growth factor release for the tendon cells.

 

Furthermore, the concentration of platelets in the leukocyte-rich preparation was 7-fold whereas in the leukocyte-poor it was 2-fold. As such, their conclusion regarding the superiority of the leukocyte-rich PRP for enhancing tendon cells growth was invalid. To be fair, the concentrations would need to be equal.

 

Dr. Bodor, Dregalla and Uribe have submitted a letter to the editor of the journal to point out their concerns, available here. With each step forward, we get closer to a future in which many of the degenerative conditions of today will not just be manageable, but curable and covered by insurance.

 

The Napa Medical Research Foundation is committed to the advancement of regenerative medicine. We believe it is essential for the scientific and medical community to work towards the development of less costly, less invasive treatments that utilize the body’s own healing agents to repair and regenerate. As researchers, medical professionals and community members, it is our duty to ensure accurate and timely information about these advances, to promote their safe and ethical use, and to prevent their misuse.

NMRF Applies for A Utility Patent

In the cutting edge of medical and scientific research, a small, non-profit organization being awarded a patent feels a lot like the story of David versus Goliath. US-based universities doing research in pharmaceuticals, biotechnology and medical technology lead the...

Welcome to Gretchen De Baubigny

The NMRF Board of Directors and Staff welcome Gretchen De Baubigny, a resident of St. Helena and San Francisco broadly respected for her creativity, warmth, and lifelong belief in the power of philanthropy. She is an advocate for issues involving education and health,...

Support Leading Edge Research

SUPPORT LEADING EDGE RESEARCH   We are incredibly fortunate to have Marko Bodor, MD and his research team here in Napa. The leading edge work they are doing is helping to change lives by reducing pain, increasing mobility, and improving quality of life.   For adults...

Invest in the Future of Regenerative Medicine

SUPPORT LEADING EDGE RESEARCH $50,000 secures a NMRF Research Fellow for 1 year. The addition of a dedicated research fellow offers the team more brain power and bandwidth during these critical early years. $25,000 underwrites the Vineyard Worker pilot program. The...

Non-Profits Are Changing the Medical Research Landscape

Save & Exit The role of non-profit foundations in the area of medical research is becoming increasingly more significant. Flexible, independent, driven by patients’ needs, funded by individual donors, and operating with a fully functional research...

A Tale of Two Knees

This is the story of one woman, two knees, and two very different treatment plans. Back in 2013, a 72-year old woman began experiencing limited range of motion and pain in her left knee and went to see her orthopedic surgeon. Having spent most of her life...

TEDxMarin event

On Saturday, September 15th, members of the Board of Directors and staff of Napa Medical Research Foundation (NMRF) joined fellow non-profits, start-ups, and other innovative companies for the 9th annual TEDxMarin Gala and Filming. Exploring The Bigger...

Frequently Asked Questions

The leading edge research being conducted by the NMRF naturally invites questions. We have been listening to our friends and neighbors around the Napa Valley and are pleased to provide a place where people can better understand regenerative medicine, discover new...

TEDxMarin Innovator Showcase

Napa Medical Research Foundation (NMRF) makes their public debut at the 2018 TEDxMarin on Saturday, September 15, 2018 at the College of Marin.   The theme of the 9th TEDxMarin Annual Gala + Filming is The Bigger Picture: Staying Human in a Digital Age. Speakers will...

A Rare Case of Causalgic Dystonia

Dystonia is a medical condition that affects more than 300,000 adults and children across the United States and is somewhat of a medical mystery. Dystonia consists of abnormal involuntary muscle activity caused by abnormal firing of nerves. It can affect writers...

Categories

 Reduce Pain. Increase Mobility + Function. Improve Quality of Life.

All the research conducted through the Napa Medical Research Foundation, a 501(c)(3) nonprofit organization, is fully funded through generous donations received from individuals and family foundations.

Pin It on Pinterest

Share This